Brief: Inhibrx Biosciences Reports Second Quarter 2024 Financial Results
13/08/2024 23:57
Aug 13 (Reuters) - Inhibrx Biosciences Inc INBX.O :
* INHIBRX BIOSCIENCES REPORTS SECOND QUARTER 2024 FINANCIAL
RESULTS AND RECENT CORPORATE HIGHLIGHTS
* QTRLY EARNINGS PER SHARE $125.48
Source text for Eikon: ID:nPn50wDLca
Further company coverage: INBX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Inhibrx Biosciences
See all newsInhibrx's combination cancer drug shrinks tumors in mid-stage head and neck cancer study (updated)
Inhibrx's combination cancer drug shrinks tumors in mid-stage head and neck cancer study
NASDAQ RESUMED AT 08:00 AM
Brief: Inhibrx's Inbrx-106 Nearly Doubles Response Rate And Achieves Interim Median Pfs Of 9.6 Months In Phase 2 Hnscc Study
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:25 AM